Abstract
The aim of this study was to report on the validity of the Naviswiss handheld image-free navigation device for accurate measurement of THA component positioning intraoperatively, in comparison with the three-dimensional (3D) reconstruction of computed tomography (CT) images as gold standard.
Methods A series of patients presenting to a single-surgeon clinic with end-stage hip osteoarthritis received primary hip arthroplasty with anterolateral muscle-sparing surgical approach in the supine position. Imageless navigation was applied during the procedure with bone-mounted trackers applied to the greater trochanter and ASIS. Patients underwent routine CT scans before and after surgery and these were analysed using three-dimensional reconstruction to generate cup orientation, offset and leg length changes which were compared to the intraoperative measurements provided by the navigation system. Estimates of agreement between the intraoperative and image-derived measurements were assessed with and without correction for bias and declared cases with potential measurement issues.
Results The mean difference between intraoperative and postoperative CT measurements was within 2° for angular measurements and 2mm for leg length. Absolute differences for the two indices were within 5° and 4mm. Mean bias was 1.9 - 3.6° underestimation for cup orientation and up to 2mm overestimation for leg length change, but absolute thresholds of 10° and 10mm were not exceeded by 95% limits of agreement (LOA), especially after correction for bias. Four cases (12%) were declared intraoperatively for issues with fixation on the greater trochanter. Inclusion of these cases generated acceptable accuracy overall and their omission failed to improve between-case variability in accuracy or LOA for both offset and leg length.
Conclusions The accuracy of the Naviswiss system applied during primary THA in supine patient position and anterolateral surgical approach falls within clinically acceptable recommendations for acetabular cup placement, femoral offset and length length. With refinements to surgical technique to adapt to the navigation hardware, the system could be further improved with regression-based bias correction.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following: CS and MF are employed by EBM Analytics, who were contracted by Naviwsiss AG to assist with completion of the protocol manuscript and data analysis for study of same device (related to submitted work). In the past 36 months, EBM Analytics has received grants or contracts from OSSIS Ltd, Headsafe Ltd, DePuy Synthes Mitek Sports Medicine and Exactech Ltd for work unrelated to the submitted manuscript. CS is a shareholder in EBM Analytics. JI received financial support from Naviswiss AG for completion of this study. In the past 36 months, JI declares the following unrelated to the current work: consulting fees from Fort Surgical; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Exactech Ltd. TS's employer was contracted by Naviswiss AG to assist with the completion of the current study. TS additionally declares stock in Naviswiss AG.
Clinical Protocols
https://bmjopen.bmj.com/content/10/10/e037126
Funding Statement
This work was funded by Naviswiss AG.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from a National Health and Medical Research Council certified human research and ethics committee (Bellberry; HREC 2017-07-499)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Upon reasonable request to the authors, only de-identified data (i.e. data with sensitive and personal information removed), will be provided as per the ANDS Publishing and Sharing Sensitive Data Guide.
